Aflac Incorporated (NYSE:AFL) Shares Sold by Prime Capital Investment Advisors LLC

Prime Capital Investment Advisors LLC lowered its position in shares of Aflac Incorporated (NYSE:AFLFree Report) by 23.3% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 15,211 shares of the financial services provider’s stock after selling 4,609 shares during the quarter. Prime Capital Investment Advisors LLC’s holdings in Aflac were worth $1,167,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of AFL. Baystate Wealth Management LLC grew its holdings in shares of Aflac by 24.1% during the third quarter. Baystate Wealth Management LLC now owns 675 shares of the financial services provider’s stock valued at $52,000 after purchasing an additional 131 shares during the last quarter. Dominguez Wealth Management Solutions Inc. grew its holdings in shares of Aflac by 0.5% during the third quarter. Dominguez Wealth Management Solutions Inc. now owns 24,969 shares of the financial services provider’s stock valued at $1,916,000 after purchasing an additional 132 shares during the last quarter. Brighton Jones LLC grew its holdings in shares of Aflac by 2.3% during the third quarter. Brighton Jones LLC now owns 6,156 shares of the financial services provider’s stock valued at $472,000 after purchasing an additional 136 shares during the last quarter. MV Capital Management Inc. grew its holdings in shares of Aflac by 3.7% during the third quarter. MV Capital Management Inc. now owns 3,779 shares of the financial services provider’s stock valued at $290,000 after purchasing an additional 136 shares during the last quarter. Finally, SVB Wealth LLC grew its holdings in shares of Aflac by 1.4% during the third quarter. SVB Wealth LLC now owns 10,370 shares of the financial services provider’s stock valued at $796,000 after purchasing an additional 140 shares during the last quarter. Institutional investors and hedge funds own 66.75% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. JPMorgan Chase & Co. upped their target price on Aflac from $74.00 to $80.00 and gave the company a “neutral” rating in a report on Thursday, November 2nd. Evercore ISI lowered Aflac from an “in-line” rating to an “underperform” rating and increased their price objective for the stock from $76.00 to $78.00 in a report on Thursday, January 4th. Morgan Stanley increased their price objective on Aflac from $75.00 to $80.00 and gave the stock an “equal weight” rating in a report on Wednesday, November 15th. Raymond James increased their price objective on Aflac from $83.00 to $88.00 and gave the stock an “outperform” rating in a report on Friday, February 2nd. Finally, Wells Fargo & Company increased their price objective on Aflac from $82.00 to $83.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 6th. Two equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $80.36.

Check Out Our Latest Report on Aflac

Insider Activity

In other news, CFO Steven Kent Beaver sold 3,114 shares of the stock in a transaction on Friday, December 1st. The stock was sold at an average price of $82.71, for a total transaction of $257,558.94. Following the completion of the sale, the chief financial officer now owns 20,914 shares in the company, valued at approximately $1,729,796.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.90% of the company’s stock.

Aflac Stock Performance

Shares of NYSE AFL opened at $78.23 on Monday. The stock has a fifty day moving average price of $82.06 and a two-hundred day moving average price of $79.22. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.08 and a current ratio of 0.08. The firm has a market cap of $45.72 billion, a P/E ratio of 10.09, a PEG ratio of 2.05 and a beta of 0.93. Aflac Incorporated has a 1 year low of $60.20 and a 1 year high of $86.20.

Aflac (NYSE:AFLGet Free Report) last issued its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). Aflac had a net margin of 24.92% and a return on equity of 17.59%. The firm had revenue of $3.78 billion for the quarter, compared to the consensus estimate of $4.44 billion. During the same period in the previous year, the business posted $1.29 earnings per share. Research analysts forecast that Aflac Incorporated will post 6.43 EPS for the current fiscal year.

About Aflac

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Further Reading

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.